US Patent 11179364 Licofligozin for the treatment of non-alcoholic steatohepatitis
Patent 11179364 was granted and assigned to Novartis on November, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11179364 Licofligozin for the treatment of non-alcoholic steatohepatitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
